Skip to main content

Ramucirumab

Generic name: ramucirumab [ RA-mue-SIR-ue-mab ]
Brand name: Cyramza
Dosage form: intravenous solution (10 mg/mL)
Drug class: VEGF/VEGFR inhibitors

Medically reviewed by Drugs.com on Dec 1, 2023. Written by Cerner Multum.

What is ramucirumab?

Ramucirumab is used to treat stomach cancer, colorectal cancer, or non-small cell lung cancer that has spread to other parts of the body. Ramucirumab may be given alone or in combination with other cancer medicines.

Ramucirumab is usually given after other treatments have failed.

Ramucirumab may also be used for purposes not listed in this medication guide.

Ramucirumab side effects

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Some side effects may occur during the injection. Tell your caregiver right away if you feel light-headed, chilled, sweaty, or have chest pain, chest tightness, back pain, trouble breathing, or numbness and tingling.

Ramucirumab can increase your risk of serious bleeding.

Ramucirumab may cause serious side effects. Call your doctor at once if you have:

Common side effects of ramucirumab may include:

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Warnings

Ramucirumab can increase your risk of serious bleeding. Stop using ramucirumab and call your doctor at once if you have severe stomach pain, bloody or tarry stools, coughing up blood, or any heavy or unusual bleeding.

Before taking this medicine

You should not use ramucirumab if you are allergic to it, or if you have:

Tell your doctor if you have ever had:

This medicine can harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medicine. Ramucirumab may affect fertility (your ability to have children).

Use birth control to prevent pregnancy while you are receiving ramucirumab, and for at least 3 months after your treatment ends.

You should not breastfeed while using this medicine.

How is ramucirumab given?

Ramucirumab is given as an infusion into a vein. A healthcare provider will give you this injection.

You may be given medication to prevent certain side effects while you are receiving ramucirumab.

Ramucirumab is sometimes given once every 2 weeks. Ramucirumab may also be given in a 21-day treatment cycle and you may only need to use the medicine during the first day of each cycle. Follow your doctor's dosing instructions very carefully.

While using ramucirumab, you may need frequent blood or urine tests. Your blood pressure will need to be checked often.

If you need surgery, tell the surgeon ahead of time that you are using ramucirumab.

Rybrevant, Opdivo, methotrexate, Keytruda, pembrolizumab, cisplatin, capecitabine, fluorouracil, Avastin, Xeloda

What happens if I miss a dose?

Call your doctor for instructions if you miss an appointment for your ramucirumab injection.

What happens if I overdose?

Since ramucirumab is given by a healthcare professional in a medical setting, an overdose is unlikely to occur.

What should I avoid while receiving ramucirumab?

Follow your doctor's instructions about any restrictions on food, beverages, or activity.

What other drugs will affect ramucirumab?

Other drugs may affect ramucirumab, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.

Does ramucirumab interact with my other drugs?

Enter medications to view a detailed interaction report using our Drug Interaction Checker.

Ramucirumab Biosimilars

Biosimilar and interchangeable products are biological products that are highly similar to and have no clinically meaningful differences from the reference product.

Reference products

These are biological products that have already been approved by the FDA, against which biosimilar products are compared. There is 1 for ramucirumab.

Cyramza (ramucirumab) - Eli Lilly and Company
Formulation type Strength
Single-Dose Vial 100 mg/10 mL (10 mg/mL)
Single-Dose Vial 500 mg/50 mL (10 mg/mL)

View Cyramza information in detail.

Further information

Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.